Eli Lilly Launches $1 Billion Hyderabad Manufacturing Hub to…

Sarah J · 2025-11-06T15:07:57.000Z

Eli Lilly and Company has announced a major $1 billion investment to expand its pharmaceutical presence in India, with a new manufacturing and quality hub planned for Hyderabad. This initiative aims to boost global medicine supply capacity and strengthen Lilly's contract manufacturing network by partnering with leading Indian pharmaceutical firms. The Hyderabad facility will serve as a technical and regulatory oversight hub, manage advanced operations, and facilitate recruitment in engineering, chemistry, analytical sciences, and quality management. Industry leaders and government officials have praised the announcement, highlighting how Lilly’s strategy leverages India’s skilled workforce and innovation ecosystem while reinforcing Hyderabad’s reputation as a center for healthcare and advanced manufacturing. The move is set to improve the supply of key medicines for chronic diseases, such as diabetes, obesity, Alzheimer's, cancer, and autoimmune conditions, aligning with Lilly’s global expansion plans and increasing capacity for future growth.

Member Login Get Access

Eli Lilly Launches $1 Billion Hyderabad Manufacturing Hub to… | SEINET